Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
UK STAR logo

The UKSTAR (UK Study of tendo Achilles Rehabilitation) trial has opened its first pilot site for recruitment. King’s College Hospital in London is now recruiting patients for the trial which is comparing plaster casts to walking boots for patients who have suffered an Achilles tendon rupture and are being treated non-operatively. The trial will gradually be rolled out with the aim of eventually opening the trial in at least 22 hospitals across the UK.

Participants who are aged 16 or over, have suffered a primary Achilles tendon rupture and are being treated non-operatively will be eligible to take part. The primary outcome for the trial is to quantify and draw inferences on observed differences in Achilles Tendon Rupture Score (a patient reported outcome) between the trial treatment groups at 9 months after injury. The trial will also collect important information for secondary outcomes on quality of life, complications, resource use, costs and comparative cost effectiveness

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.